Robinhood Markets dropped 15% after its April 28 earnings release — yet the data reveals a stock where short sellers are rebuilding gradually, not aggressively, and where options positioning is unusually calm.
The earnings reaction was the week's defining event. After reporting on April 28, shares fell 15.2% in a single session before partially recovering over the following week. The stock closed at $77.03 on May 5, still down 6.1% over the week and roughly 15% below the pre-earnings highs above $90. That's a sharp post-print reset — but the subsequent trajectory, including a small 0.6% bounce on the latest session, suggests the flush has found at least a temporary floor.
Short positioning tells a measured story, not an aggressive one. Short interest climbed to 4.4% of the free float by May 5, up from 3.9% in mid-March — a steady build, but nowhere near what one might expect given the magnitude of the earnings sell-off. The pace of accumulation is slow: roughly 1% week-on-week. Borrow costs remain negligible at 0.47% annualised, and availability in the lending market is loose, with the borrow utilisation running near 5% against a 52-week high of 9.7%. There is no meaningful squeeze pressure and no sign of a crowded short. Options reinforce the same picture. The put/call ratio of 0.67 is almost exactly in line with its 20-day average of 0.67 and z-score of just 0.2 — essentially no directional lean in the options market, despite the recent carnage in the stock.
The Street's reaction to the earnings miss was largely to trim targets while maintaining positive ratings — a grudging hold rather than a wholesale downgrade. Multiple firms cut price targets in the two days after the print: Barclays moved to $82 from $89 (maintaining Overweight), Needham cut to $85 from $95 (Buy), and JPMorgan trimmed to $92 from $113 (Neutral) in the run-up. The mean target now sits at $98, implying roughly 27% upside to the current price — a wide gap that reflects the divergence between the bull and bear camps. Bulls point to an expected 10% top-line growth trajectory in 2026, international expansion, and crypto tokenisation opportunities. Bears counter that heavy reliance on volatile asset classes, crypto-driven revenue, and the looming regulatory risk around payment for order flow make the earnings base fragile. One outlier on the Street — Citizens — reiterated a $155 target, which is almost double the current price; that figure warrants scepticism as a standalone data point and may reflect a particularly optimistic scenario model. The PE multiple has expanded over 30 days to around 33.7x, up roughly 25% on a 30-day look, reflecting the fact that the price fell less than earnings expectations were revised downward post-print.
Founder selling adds a layer of context worth noting. Co-founder Baiju Bhatt sold approximately $4.9 million of stock around April 16, before the print, in multiple tranches near $84–$88. CTO Jeff Pinner also sold around $490,000 on April 27. The net 90-day insider figure is positive at roughly 472,000 shares, suggesting the selling is offset by other activity — likely option awards — but the cluster of founder and C-suite sales at higher prices than where the stock now trades is a data point the market will be aware of.
Peer performance this week offers some comparative context. COIN slipped 2.6% on the day while IBKR gained 2.7% and ETOR added 1.6%. The relative underperformance of HOOD against several fintech and crypto-adjacent peers through the week suggests the earnings reaction is still being digested specifically at the stock level, rather than being purely a sector move.
The next confirmed event is a June 2 earnings call. With targets spread between $65 and $155, short interest building at a measured pace, and options flat, the key question heading into that date is whether the April sell-off reflected a one-quarter disappointment or a re-rating of the underlying growth trajectory.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
